Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Background Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in this clinical context. Methods...
Saved in:
| Published in: | New England Journal of Medicine 2020-06 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Online Access: | Request full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|